This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
NuGen Medical Devices Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
NuGen Medical Devices Inc. Receives Two Additional Sales Orders for InsuJet and Expands Distribution into Argentina, Chile, Costa Rica and Peru CI
NuGen Medical Devices Inc. Signs 5-Year Distribution Agreement for InsuJet with Verrue Consulting Group in Belgium CI
NuGen Medical Signs 5-Year Distribution Agreement for InsuJet with Advance Medical Life CI
NuGen Medical Devices Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
NuGen Medical Devices Inc. Reports Distribution Agreement with Science-Link Trading SAPI de CV CI
Nugen Medical Devices Inc. Announces the Official Launch on Shopify of Its Diabetic's Lifestyle Subscription Business CI
NuGen Medical Devices Inc. Announces Chief Executive Officer Changes CI
NuGen Medical Devices Inc. Presents New Data from Preliminary Trial That Semaglutide (Ozempic ) Is Chemically Stable After It Is Administered Through Nugen 's InsuJet Needle-Free Injection Device CI
NuGen Medical Devices Inc. Completes Delivery and First Sale of 500 InsuJet Devices and Consumables in Romania CI
NuGen Medical Devices Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
NuGen Medical Devices Inc. Enters into Distribution Agreement with Sol-Millennium Medical Inc CI
NuGen Medical Devices Inc. Announces Executive Changes CI
Nugen Medical Devices Inc. Announces InsuJetTM Now Registered for Supply Through Reliance Medical Group CI
NuGen Medical Devices Inc. Receives its First Bulk Purchase Order from Science-Link Trading SAPI de CV for the Mexican Market for 500 Units of the Company's Needly-Free InsuJet InsuJet InsuJet™? Injection Device CI
NuGen Medical Devices Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
NuGen Medical Devices Up 2.3% After Reporting Closing of Non-Brokered Private Placement of Units MT
NuGen Medical Devices Inc. announced that it has received CAD 0.45 million in funding CI
NuGen Medical Devices Inc. Auditor Raises 'Going Concern' Doubt CI
NuGen Medical Devices Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
NuGen Medical Devices Inc. announced that it has received CAD 4 million in funding CI
NuGen Medical Devices Inc. Engages Basic Pharma Technologies to Perform an Assessment and Feasibility Study CI
NuGen Medical Devices Inc. announced that it expects to receive CAD 3.6 million in funding CI
NuGen Medical Devices Inc. Engages with Sol-Millennium CI
NuGen Medical Devices Inc. Re-Appoints Veronique Laberge as Corporate Secretary CI
Chart NuGen Medical Devices Inc.
More charts
NuGen Medical Devices Inc. is a Canada-based specialty medical device company. The Company is engaged in marketing and selling its InsuJet needle-free injection system designed to improve the lives of millions of diabetics. Its principal business is the research, development and commercialization of needle-free injection devices and systems for the administration of subcutaneous medication. It is developing products using its needle-free delivery technology in several fields including, but not limited to, diabetes, semaglutide, growth and fertility hormone, as well as deoxyribonucleic acid (DNA) and conventional/pediatric vaccines. It is focusing its development efforts on needle free devices in the area of liquid jet delivery through the InsuJet platform. The Company's InsuJet technology platform is based on jet-stream administration of liquid drugs. The Company manufactures and commercializes needle-free injection systems and sells in over 40 countries globally.
More about the company
  1. Stock Market
  2. Equities
  3. NGMD Stock
  4. News NuGen Medical Devices Inc.
  5. NuGen Medical Devices Up 2.3% After Reporting Closing of Non-Brokered Private Placement of Units